ADAMTS13 siRNA

siRNA / miRNA gene silencing Human - HUVEC ADAMTS-13

Experiment
siRNA / miRNA gene silencing Human - HUVEC ADAMTS-13
Product
ADAMTS13 siRNA from Thermo Fisher Scientific
Manufacturer
Thermo Fisher Scientific

Protocol tips

Protocol tips
Human umbilical vein endothelial cells (HUVEC) were isolated from human umbilical veins as previously described (Tao et al., 2005) and cultured in M199 media supplemented with 20% fetal bovine serum penicillin, streptomycin, and amphotericin (Fungizone™). Upon reaching confluence, primary cultures of HUVEC were passaged using 0.25% trypsin/EDTA. Second-passage HUVEC were utilized in all assays. 24 h prior to the start of the knockdown assay, 2 × 105 first-passage HUVEC were added to a six-well plate in 2 ml of M199 media containing 20% FBS with antibiotics, such that approximately 60–80% confluence would be reached by the time of assay. The control and ADAMTS-13 siRNA knockdown assays were carried out according to the manufacturer's protocol. The cells or the cell lysates were harvested after 24 h incubation. ADAMTS-13 protein level in cell lysates from HUVEC treated with control siRNA or three different ADAMTS-13 siRNAs (s21868, s21869 and s21870). 15 nM siRNA was used for each transfection. After 24 h, cell lysates were harvested, concentrated and assayed with an ADAMTS-13 ELISA kit.

Publication protocol

Human umbilical vein endothelial cells (HUVEC) were isolated from human umbilical veins as previously described (Tao et al., 2005) and cultured in M199 media supplemented with 20% fetal bovine serum penicillin, streptomycin, and amphotericin (Fungizone™). Upon reaching confluence, primary cultures of HUVEC were passaged using 0.25% trypsin/EDTA. Second-passage HUVEC were utilized in all assays. 24 h prior to the start of the knockdown assay, 2 × 105 first-passage HUVEC were added to a six-well plate in 2 ml of M199 media containing 20% FBS with antibiotics, such that approximately 60–80% confluence would be reached by the time of assay. The control and ADAMTS-13 siRNA knockdown assays were carried out according to the manufacturer's protocol. The cells or the cell lysates were harvested after 24 h incubation. ADAMTS-13 protein level in cell lysates from HUVEC treated with control siRNA or three different ADAMTS-13 siRNAs (s21868, s21869 and s21870). 15 nM siRNA was used for each transfection. After 24 h, cell lysates were harvested, concentrated and assayed with an ADAMTS-13 ELISA kit.

Full paper   Login or join for free to view the full paper.

Reviews

ADAMTS13 siRNA from Thermo Fisher Scientific has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - HUVEC ADAMTS-13 using ADAMTS13 siRNA from Thermo Fisher Scientific.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Thermo Fisher Scientific for ADAMTS13 siRNA below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - HUVEC ADAMTS-13 using ADAMTS13 siRNA from Thermo Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms